•  
  •  
  •  
  •  

2025-10-02 06:11:43

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue

Keywords Selected:  INE176A01028

Stock Report

  • Bata India announces Q1 FY26 results - Inventory & Product merch agility improves
  • Bata Group Appoints New Chief Executive Officer
  • Bata India announces VRS at Bata Shatak Unit, Hosur
  • Bata India partners with Zepto for 10-minute footwear delivery
  • Bata India launches limited-edition Emily in Paris line-up featuring rising star Sharvari
  • Bata India launches latest Power Energy Collection
  • Bata India approves closure of Southcan Unit, Karnataka
  • Bata India appoints Deepika Deepti as Head of Marketing
  • Bata India announces Q4 results
  • Explore the world with Bata's latest 'Try and Fly' campaign featuring 9 to 9 Collection
  • Bata India Ltd receives Rs. 154.44 crores from Faridabad land sale
  • 'Power' Exclusive Brand Outlets Make a Powerful Entry in India
  • Bata Marks landmark achievement with 500 Franchise Stores in India
  • Bata India Ltd recommends dividend of Rs. 13.50
  • LIC increases stake in BATA India Ltd
  • Bata India unveils campaign to promote its Sneaker Studios
  • Bata India becomes the first footwear brand in India to launch 3D OOH Billboard
  • Promoter of Bata India to hold more than 50.1% stake in Indian arm
  • BATA India Ltd Board recommends Dividend of Rs. 54.5

Latest Post

  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024